iMyFone DreamVid AI Picture Generation Video - Redefining Visual Creation

TAIPEI,Feb. 28,2025-- In the era of ever-changing digital image technology,how to make still photos more vivid? How to make memories more vivid?iMyFone announces the release of iMyFone DreamVid,an AI

Bambusa Therapeutics Announces First Subject Dosed in Phase 1 Clinical Trial of BBT001, a Novel Multi-Targeting, Half-Life Extended Bispecific Antibody for the Treatment of Atopic Dermatitis and Other Inflammatory Skin Diseases

Preclinical data with BBT001 demonstrate its best-in-disease potential for improved efficacy and dosing convenience compared to approved biologics in atopic dermatitis

Great Tea Road Retracing: A Journey Along the Ancient Tea Trade Route

WUHAN,China,Feb. 28,2025-- The documentary seriesGreat Tea Road Retracing is produced by Hubei Daily Net. In the series,American tea enthusiast Hannah Carter takes viewers on an exploration along the

Lanvin Group Prioritizes Creative Renewal and Operational Agility Amid Evolving Luxury Landscape

Revenue of €328 million in FY2024,a 23% decrease over FY2023,reflecting a transitional year marked by creative evolution and strategic realignment amid marketheadwinds

Tuya Smart x DeepSeek: The Revolutionary Path Empowered by Emotional Home Robots

NEW YORK,Feb. 28,2025-- Tuya Smart (NYSE: TUYA,HKEX: 2391),a global AI cloud platform service provider,has integrated the DeepSeek large language model into its AIoT platform,helping global developers

Aduna and Bridge Alliance partner to accelerate access to network APIs

STOCKHOLM,March 2,2025-- Aduna,a landmark venture between some of the world\'s leading telecom operators and Ericsson,is set to partner with Bridge Alliance to accelerate the adoption of CAMARA-based

DXC Names Former COO at Federal Reserve, Pat McClanahan, as Global Leader of Business and Sales Operations for Consulting & Engineering Services

ASHBURN,Va.,Feb. 27,2025-- DXC Technology (NYSE: DXC),a leading Fortune 500 global technology services provider,today announced the appointment of Pat McClanahan as Global Leader of Business and Sale

First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer

SUZHOU,China,Feb. 27,2025-- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been su

Minesto publishes Year-End Report 2024

GOTHENBURG,Sweden,Feb. 27,2025-- CEO Dr. Martin Edlund: "Minesto has now demonstrated competitive renewable energy production from an untapped natural resource based on a truly novel and propriet

Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform

Metabolon\'s expertise extends beyond metabolomics to include data insights and software solutions for multiomics research